Look for:

Our offer for

REGENERON PHARMACEUTICALS INC.


ISIN:
US75886F1075
WKN:
75886F107

2019/11/20 17:30:18
Price
346.7695 USD
Difference 0.67% (2.31)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)33,300 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)346.46 USD (100)
Ask (Ask size)346.77 USD (200)
Open341.98 USD
High347.42 USD
Low341.98 USD
Close (prev. day)344.46 USD
VWAP345.967394 USD
Volume (pcs)178,348
Trading volume61,704,640.37
Number of trades3,830
Last size100

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: REGENERON PHARMACEUTICALS INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2019/11/20 17:30:18
Price
346.7695 USD
Difference 0.67% (2.31)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)33,300 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)346.46 USD (100)
Ask (Ask size)346.77 USD (200)
Open341.98 USD
High347.42 USD
Low341.98 USD
Close (prev. day)344.46 USD
VWAP345.967394 USD
Volume (pcs)178,348
Trading volume61,704,640.37
Number of trades3,830
Last size100

Performance and Risk

6m1Y3Y
Perf (%)+12.96%+1.61%-13.34%
Perf (abs.)+39.52+5.47-53.02
Beta0.931.091.04
Volatility28.5131.1530.54
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)343.2420 USD (844,356)
Ø price 30 days | Ø volume 30 days (pcs.)316.9557 USD (804,382)
Ø price 100 days | Ø volume 100 days (pcs.)301.3038 USD (742,203)
Ø price 250 days | Ø volume 250 days (pcs.)342.8619 USD (770,461)
YTD High | date442.0000 USD (2019/03/04)
YTD Low | date271.3700 USD (2019/09/27)
52 Weeks High | date442.0000 USD (2019/03/04)
52 Weeks Low | date271.3700 USD (2019/09/27)

All listings for REGENERON PHARMACEUTICALS INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2019/11/2009:05310.05 EUR0.001
Tradegate2019/11/2016:52311.90 EUR0.015
Stuttgart2019/11/2015:44310.45 EUR0.008
Nasdaq2019/11/2017:30346.7325 USD61.773,832
Munich2019/11/2016:43311.65 EUR0.007
London Stock Exchange2019/09/2318:31294.7645 USD0.012
Hamburg2019/11/2008:01308.55 EUR0.001
Frankfurt2019/11/2014:48311.00 EUR0.002
Duesseldorf2019/11/2017:07312.40 EUR0.006
Berlin2019/11/2016:43311.45 EUR0.007

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=99472&ID_TYPE_IMAGE_LOGO=2

Contact Details

REGENERON PHARMACEUTICALS INC.
- -
Old Saw Mill River Road 777 10591-6707 Tarrytown, New York
Telefon: +1-914-847-7000
Fax: -
E-mail: invest@regeneron.com

PDF Downloads

Company report: REGENERON PHARMACEUTICALS INC.PDF Download

Company Profile

Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases.

Members of Management Board

P. Roy Vagelos, M.D.Chairman of Board of Directors
Tony Coles, M.D.Member of Board of Directors
Michael S. Brown, M.D.Member of Board of Directors
Joseph L. Goldstein, M.D.Member of Board of Directors
Huda Y. Zoghbi, M.D.Member of Board of Directors
George L. SingMember of Board of Directors
Christine A. PoonMember of Board of Directors
Arthur F. RyanMember of Board of Directors
Marc Tessier-LavigneMember of Board of Directors
Leonard S. SchleiferMember of Board of Directors
George D. YancopoulosMember of Board of Directors
Bonnie L. BasslerMember of Board of Directors
Leonard S. SchleiferChairman of Managing Board
Robert E. LandryMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer